WS #16247
Abbott Laboratories announced plans to spin off its $8.5 billion Nutrition business via a tax-free distribution by the end of 2027. This strategic move aims to unlock value in the high-growth nutrition segment while allowing Abbott to focus on its medical technology and pharmaceutical divisions. The spinoff is expected to be accretive to both entities and is viewed positively by analysts for its clarity of focus.
Abbott Nutrition Spinoff
Abbott Laboratories announced plans to spin off its $8.5 billion Nutrition business via a tax-free distribution by the end of 2027. This strategic move aims to unlock value in the high-growth nutrition segment while allowing Abbott to focus on its medical technology and pharmaceutical divisions. The spinoff is expected to be accretive to both entities and is viewed positively by analysts for its clarity of focus.